Inventor · disambiguated record
Gabriel Rabinovich
Also filed as: RABINOVICH GABRIEL · RABINOVICH GABRIEL A · RABINOVICH GABRIEL ADRIAN · RABINOVICH GABRIEL ADRIÁN
9 granted patents·4 pending applications·13 citations·filing 2008–2022
81Inventor score
Files withSHIPP MARGARET A4DANA FARBER CANCER INST INC3CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN2INIS BIOTECH LLC2CONSEJO NAC INVEST CIENT TEC1
Top patents by PatentIndex Score
13 records- 0183US9206427B2Compositions, kits, and methods for the modulation of immune responses using galectin-1SHIPP MARGARET A·Filed 2008·Granted Dec 8, 2015·4 cites·6 claims
- 0282US8968740B2Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1SHIPP MARGARET A·Filed 2010·Granted Mar 3, 2015·7 cites·14 claims
- 0372US11723972B2Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1DANA FARBER CANCER INST INC·Filed 2019·Granted Aug 15, 2023·0 cites·8 claims
- 0468US10456465B2Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1DANA FARBER CANCER INST INC·Filed 2015·Granted Oct 29, 2019·1 cites·22 claims
- 0566US10294295B2Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatmentINIS BIOTECH LLC·Filed 2014·Granted May 21, 2019·1 cites·16 claims
- 0657US2009004259A1Methods of preparing a therapeutic formulation comprising galectin-induced tolerogenic dendritic cellsCONSEJO NAC INVEST CIENT TEC·Filed 2008·Application pending·0 cites
- 0756US2019212330A1Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1SHIPP MARGARET A·Filed 2018·Application pending·0 cites
- 0854US2025041362A1Galectin-1 delivery for therapeutic control of intestinal inflammationUNIV NACIONAL DE ROSARIO·Filed 2022·Application pending·0 cites
- 0952US9939428B2Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1SHIPP MARGARET A·Filed 2008·Granted Apr 10, 2018·0 cites·16 claims
- 1049US2016187340A1Compositions, Kits, and Methods for the Modulation of Immune Responses Using Galectin-1DANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
- 1148US10456447B2Therapeutic modulation of skin immune system with Gal-7CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN·Filed 2017·Granted Oct 29, 2019·0 cites·5 claims
- 1238US11020478B2Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatmentINIS BIOTECH LLC·Filed 2019·Granted Jun 1, 2021·0 cites·23 claims
- 1328US10000548B2GAL-1 variants having immuno-modulating properties and methods of using the sameCONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECN·Filed 2016·Granted Jun 19, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Gabriel Rabinovich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →